Anne-Sophie Grell

Manager Regulatory Affairs – Medical Devices | PhD in Physics | MSc in Medical Physics

Anne-Sophie Grell is a highly respected Regulatory Affairs leader with over two decades of multidisciplinary experience in medical physics, diagnostic imaging, and medical device regulation. At QbD Group, she supports clients navigating EU MDR, FDA, and international regulatory frameworks, especially for high-tech devices in radiology, radiotherapy, and proton therapy.

Biography

Anne-Sophie Grell holds a PhD in Physics (2001) and a Master’s in Medical Physics (2006). She began her career as a researcher and physics control lead in medical imaging at the Institut Jules Bordet, and quickly established herself as a trusted authority in radiology quality control and medical device compliance.

Her deep expertise earned her appointments as board member of the Belgian Association for Medical Physicists and effective member of the Belgian Federal Health Agency’s medical device evaluation commission. In 2010, she transitioned to the industry side, joining IBA as QA/RA Manager, and later RA Director, overseeing both medical and non-medical device portfolios.

At IBA, Anne-Sophie led global registration strategies and was instrumental in proton therapy upgrade projects. She later joined Philips IGTD as Senior RA Expert and APAC Regional Lead, managing submissions and market access across Russia, China, India, New Zealand, and more.

Since 2021, she has been Manager RA PD at QbD, where she leads regulatory strategies for X-ray, MRI, radiotherapy, and AI-powered imaging devices, with a strong focus on EU MDR, ISO 13485, ISO 14971, and global market registration.

Regulatory Affairs  Our Services - QbD Group

Anne-Sophie's key areas of expertise

Medical Imaging & Radioprotection

Physics control, quality assurance, and compliance strategies for X-ray, mammography, MRI, and radiotherapy devices.

EU MDR, FDA & Global Regulations

Extensive hands-on experience with EU MDR 2017/745, FDA 21 CFR Part 820, ANVISA, and regulatory pathways across Asia and Latin America.

Proton Therapy & High-Risk Device Registration

Proven track record of leading successful registrations for highly innovative and complex devices globally.

Technical Documentation & PRRC Expertise

Deep knowledge of regulatory dossier structure, PRRC responsibilities, and automated documentation systems.
an award concept with a life sciency background

Awards, Recognitions & Affiliations

  • Board Member, BHPA (2007–2010)
  • Expert in Medical Physics – FANC, 2007
  • Recognized expert in mammography screening – Belgian Ministry, 2010
  • RAPS Member (2010–2019, 2021–present)
  • ISO 13485 Internal Auditor – Certified by BSI
  • Member of Team PRRC (2022–present)

Explore our expert content

preview_image
Blog

Strategic Choices That Define a Biotech’s Path to the Clinic: First-in-Human Is Earned Long Before It Begins

For early-stage biotech teams, the most consequential decisions are...
preview_image
Blog

EU MDR Bottleneck Ahead: Why 2026 Will Be a Defining Year for Medical Device Manufacturers

The clock is ticking for medical device manufacturers operating in...
preview_image
Blog

The Critical Role of the CH-REP in Swiss Market Access

If you are a manufacturer of medical devices or in vitro diagnostic...
preview_image
Blog

The UK Responsible Person (UKRP): Your Official Representative and First Step into the UK Market

For medical device and in vitro diagnostic (IVD) manufacturers...
preview_image
Blog

Your Gateway to the EU Market: The Crucial Role of the Authorised Representative

For medical and in vitro diagnostic device manufacturers based...
preview_image
Blog

MHRA publishes new IVD Roadmap

The roadmap sets out broad timelines and planned activities across three key...
preview_image
Blog

Proposal for a Regulation Amending MDR and IVDR

The proposal introduces wide-ranging changes across the device lifecycle. It...
preview_image
Blog

Draft EU Implementing Act on Notified Body Procedure Published

The feedback period runs from 12 December 2025 to 23 January 2026. The draft...
preview_image
Blog

MDCG on Breakthrough Devices Released

The guidance sets out the criteria for BtX designation, requiring devices to...
preview_image
Blog

New Update of Appendix 1 of the Nitrosamines Guideline - EMA/42261/2025/Rev. 11

What's new? This update introduces the Acceptable Intake (AI) values for new...
overlay
Webinar - ATMP Supply Chain Navigating the Challenges and Exploring the Vein-to-Vein Strategy - QbD Group (2)

Don't miss the latest updates in life sciences

Circles_banner_short-1